News

Over 400,000 people have enrolled in a study, conducted by Stanford and Apple, to determine whether a wearable technology can identify irregular heart rhythms suggestive of atrial fibrillation.

Researchers have taught an artificial intelligence program used to recognise faces on Facebook to identify galaxies in deep space. The result is an AI bot named ClaRAN that scans images taken by radio telescopes.

Catching cells in the act of switching from 'pumping' to 'repair' mode with the use of single-cell RNA sequencing should raise alarms, researchers say.

ImmusanT initiates phase 2 enrolment for its lead therapeutic vaccine candidate in patients with celiac disease.

A stunning report concludes that researchers often ask statisticians to make "inappropriate requests." Not accidental requests for incorrect statistical analyses; but unscrupulous data manipulation or even fraud.

Endocrinologists are focusing on PAPPA2, a rare mutation, to support healthy growth and development in people with height disorders.

A drug discovery made at the University of Helsinki’s Faculty of Veterinary Medicine will increase the safety of animal sedation and anaesthesia. Vatinoxan, the pharmacological molecule discovered in the study, reduced the adverse effects of other drugs on the cardiovascular system of canine patients.

Babies exposed in the womb to the majority of medications that target neurotransmitter systems, including typical targets of antidepressants and antipsychotic drugs, are not any more likely to develop autism than non-exposed babies, according to research conducted at The Seaver Autism Center for Research and Treatment at the Icahn School of Medicine at Mount Sinai.

Researchers have found that the removal of mesencephalic astrocyte–derived neurotrophic factor MANF specifically from β-cells in adult mice results in the loss of β-cells in diabetes.

Researchers have provided fundamental new insight into the mechanism of the medical drug dimethyl fumarate, which is the active component of important treatments for multiple sclerosis and psoriasis. The results contribute to the development of new strategies for drug discovery.